European Society of Medicine

ESMED small

Neurodegenerative Disease Committee

Home  >  Global Health Center > Neurodegenerative Disease Committee

Neurodegenerative Disease Committee

Explore our initiatives to lower the burden of neurodegenerative diseases in Europe and beyond.

What we want to achieve

We are dedicated to advancing the understanding, treatment, and prevention of neurodegenerative diseases through collaborative research and innovation. By bringing together leading researchers, clinicians, and advocates, we work to accelerate scientific breakthroughs and translate discoveries into meaningful treatments that can improve outcomes for patients and families affected by these conditions.

We envision a future where neurodegenerative diseases are effectively managed and ultimately prevented—where patients and families worldwide benefit from cutting-edge therapies, improved diagnostic tools, and comprehensive care approaches. Together, we are committed to driving progress in neurological research and ensuring that scientific advances lead to real-world improvements in the lives of those facing these challenging conditions.

Focus areas

Alzheimer's Disease

Multiple Sclerosis

Dementia

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis

Committee members

Sara Houston

University of Roehampton

Ritchie Shoemaker

Center for Research on Biotoxin Associated Illnesses & ProgeneDx LLC

Jane Murray

Northumbria University

Latest publications

Research Article

Real-Time Alzheimer's Detection using Deep Vision Models

Early detection of Alzheimer’s disease is essential for timely intervention, but traditional diagnostic tools often fall short due to their reliance on manual evaluation and limited sensitivity.

By Yashwanth Reddy Akkidi & Wisam Bukaita, Lawrence Technological University

Policy Framework

Reducing the Burden of Neurodegenerative Diseases in Europe and Beyond

The European Society of Medicine emphasizes the urgent need to address the increasing burden of neurodegenerative diseases in Europe. This comprehensive policy framework provides a roadmap for tackling these complex conditions through a multifaceted approach that includes advancements in diagnostics, treatment modalities, long-term management strategies, and equitable access to care.

Case report

Case of Early-onset Dementia with Lewy Bodies Associated with PRKN Gene Mutation

This report reveals a potential unique association of the PRKN mutation with early-onset dementia with Lewy bodies.

By Leila Lotfi & Neeraj Singh, Northwell Health Neurosciences Institute

Theme issues

Upcoming

Disease-Modifying Therapies for Multiple Sclerosis

Emerging Therapies for Huntington's Disease

Caregiver Support Systems in Dementia Care

Digital Health Technologies for Neurodegenerative Disease

Emerging Paradigms in Parkinson's Disease Treatment

Published

Researching neurodegenerative diseases?

We would like to hear from you. Write to us at [email protected]

Call for papers

Have a manuscript to publish in the society's journal?